TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
AGEN

Agenus Inc

Healthcare · Biotechnology

8.30$ -16.1% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow AGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-12.80 -12.06 -18.37 -19.15 -23.67 -2.77 -16.13 0.89 -12.45 -12.53 -7.37 -5.32
0.53 3.63 1.14 1.22 1.14 0.99 0.83 0.59 0.49 0.76 0.62 0.45
1.56 1.90 3.03 2.53 1.38 1.47 1.21 1.71 1.30 1.28 0.81 0.58
2.90 8.21 7.28 5.47 7.55 8.59 2.98 3.23 5.00 – – –
-2.01 1.69 2.39 -1.32 0.03 8.70 1.04 -0.85 1.71 0.60 1.52 0.92
0.94 0.92 2.88 0.63 0.65 0.69 0.40 2.95 3.77 0.56 0.03 0.02
-5.63 -7.99 4.04 0.42 -0.65 -0.69 -0.51 -3.77 -2.39 0.19 0.00 0.00
0.15 0.00 0.27 3.25 0.00 – – 0.80 – – – –
-0.15 28.55 -0.15 -0.11 15.53 4.45 20.45 -0.14 -0.27 -0.29 0.00 0.00
-1.12 27.14 -0.03 2.98 -29.27 -0.05 0.34 -0.12 -0.03 -0.50 0.44 0.08
17.68 48.48 -0.57 16.37 23.16 4.64 21.32 19.68 6.80 6.70 5.72 4.13
-0.55 28.38 -14.99 -2.29 -1.29 1.30 4.72 16.78 -8.04 -5.68 -1.66 -1.20
-13.74 -12.98 -21.24 -19.78 -24.32 -3.46 -16.53 -2.07 -16.22 -13.09 -7.40 -5.34

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?